Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 29 | 2024 | 1099 | 2.560 |
Why?
|
| Heart Transplantation | 13 | 2022 | 887 | 1.260 |
Why?
|
| Heart, Artificial | 6 | 2018 | 69 | 1.240 |
Why?
|
| Heart Failure | 19 | 2024 | 2429 | 1.240 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 375 | 0.710 |
Why?
|
| Models, Cardiovascular | 3 | 2018 | 176 | 0.680 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 507 | 0.500 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 67 | 0.430 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2005 | 211 | 0.370 |
Why?
|
| Thrombosis | 3 | 2014 | 544 | 0.350 |
Why?
|
| Assisted Circulation | 2 | 2014 | 36 | 0.340 |
Why?
|
| Heart Ventricles | 4 | 2017 | 783 | 0.320 |
Why?
|
| Prosthesis Design | 6 | 2019 | 663 | 0.310 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2008 | 59 | 0.310 |
Why?
|
| Pulsatile Flow | 4 | 2016 | 114 | 0.280 |
Why?
|
| Myocardium | 4 | 2018 | 907 | 0.270 |
Why?
|
| Plasma Exchange | 1 | 2008 | 89 | 0.270 |
Why?
|
| Pulse | 1 | 2006 | 26 | 0.260 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2005 | 52 | 0.250 |
Why?
|
| Preoperative Care | 1 | 2008 | 373 | 0.240 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 172 | 0.220 |
Why?
|
| Transplantation, Heterotopic | 2 | 2014 | 29 | 0.220 |
Why?
|
| Middle Aged | 22 | 2024 | 29081 | 0.210 |
Why?
|
| Stroke | 4 | 2024 | 1079 | 0.210 |
Why?
|
| Jehovah's Witnesses | 1 | 2023 | 17 | 0.200 |
Why?
|
| Treatment Outcome | 13 | 2022 | 13101 | 0.200 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2010 | 1162 | 0.200 |
Why?
|
| Aorta | 1 | 2006 | 548 | 0.190 |
Why?
|
| Bioprosthesis | 3 | 2018 | 117 | 0.190 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 338 | 0.190 |
Why?
|
| Aged | 17 | 2024 | 21584 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 685 | 0.190 |
Why?
|
| Male | 28 | 2024 | 65658 | 0.180 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 169 | 0.180 |
Why?
|
| Machine Learning | 1 | 2024 | 348 | 0.170 |
Why?
|
| Humans | 36 | 2024 | 133529 | 0.170 |
Why?
|
| Survival Rate | 4 | 2019 | 2203 | 0.160 |
Why?
|
| Mitochondria | 1 | 2024 | 757 | 0.150 |
Why?
|
| Anemia | 1 | 2023 | 350 | 0.150 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2019 | 47 | 0.150 |
Why?
|
| Bioartificial Organs | 1 | 2018 | 11 | 0.150 |
Why?
|
| Hemodynamics | 4 | 2016 | 819 | 0.150 |
Why?
|
| Materials Testing | 1 | 2018 | 77 | 0.140 |
Why?
|
| Adult | 21 | 2022 | 31787 | 0.140 |
Why?
|
| Female | 24 | 2024 | 71561 | 0.140 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 84 | 0.140 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 156 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 241 | 0.130 |
Why?
|
| Equipment Design | 4 | 2016 | 598 | 0.130 |
Why?
|
| Tissue Engineering | 1 | 2018 | 179 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 152 | 0.120 |
Why?
|
| Hemorheology | 1 | 2015 | 22 | 0.120 |
Why?
|
| Cattle | 4 | 2018 | 586 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 77 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1191 | 0.110 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 21 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 338 | 0.110 |
Why?
|
| Time Factors | 5 | 2010 | 6545 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2022 | 17580 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 2014 | 121 | 0.100 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 644 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2012 | 463 | 0.100 |
Why?
|
| Hemorrhage | 2 | 2013 | 517 | 0.100 |
Why?
|
| Thromboembolism | 2 | 2010 | 93 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2013 | 5205 | 0.090 |
Why?
|
| Ventricular Function, Left | 2 | 2012 | 542 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2014 | 418 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1888 | 0.090 |
Why?
|
| Miniaturization | 1 | 2009 | 25 | 0.080 |
Why?
|
| Transposition of Great Vessels | 1 | 2010 | 136 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 342 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2009 | 73 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 596 | 0.070 |
Why?
|
| Young Adult | 6 | 2013 | 9980 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2010 | 1584 | 0.070 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2008 | 9 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2009 | 112 | 0.070 |
Why?
|
| Bleeding Time | 1 | 2008 | 8 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 7197 | 0.070 |
Why?
|
| Prothrombin Time | 1 | 2008 | 38 | 0.070 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 213 | 0.070 |
Why?
|
| Partial Thromboplastin Time | 1 | 2008 | 50 | 0.070 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 82 | 0.070 |
Why?
|
| Bilirubin | 1 | 2008 | 131 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2015 | 442 | 0.070 |
Why?
|
| United States | 5 | 2022 | 11761 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 965 | 0.070 |
Why?
|
| Cause of Death | 2 | 2009 | 504 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2008 | 322 | 0.060 |
Why?
|
| Creatinine | 1 | 2008 | 417 | 0.060 |
Why?
|
| Sheep | 1 | 2006 | 231 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 358 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2017 | 3170 | 0.060 |
Why?
|
| Blood Transfusion | 2 | 2023 | 296 | 0.060 |
Why?
|
| Adolescent | 8 | 2013 | 20606 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2005 | 1136 | 0.060 |
Why?
|
| Brachiocephalic Trunk | 1 | 2005 | 40 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 409 | 0.060 |
Why?
|
| Hemolysis | 2 | 2018 | 114 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 629 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 126 | 0.050 |
Why?
|
| Heart | 2 | 2014 | 692 | 0.050 |
Why?
|
| Caveolins | 1 | 2003 | 15 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 1467 | 0.050 |
Why?
|
| Device Removal | 1 | 2005 | 224 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 2 | 2003 | 314 | 0.050 |
Why?
|
| Quality of Life | 4 | 2022 | 2160 | 0.050 |
Why?
|
| Animals | 6 | 2018 | 36121 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 38 | 0.050 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2003 | 88 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 313 | 0.050 |
Why?
|
| Biopsy | 1 | 2005 | 1298 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2002 | 302 | 0.040 |
Why?
|
| Prosthesis Failure | 2 | 2012 | 162 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 203 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 430 | 0.040 |
Why?
|
| Outpatients | 2 | 2013 | 277 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2003 | 465 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 3097 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 1431 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 404 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 71 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2003 | 518 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 893 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 341 | 0.030 |
Why?
|
| Gene Expression | 1 | 2002 | 1608 | 0.030 |
Why?
|
| Benchmarking | 1 | 2018 | 146 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 205 | 0.030 |
Why?
|
| Pressure | 1 | 2016 | 133 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 113 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2015 | 15 | 0.030 |
Why?
|
| Biomarkers | 1 | 2005 | 3417 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1196 | 0.030 |
Why?
|
| Microvessels | 1 | 2015 | 62 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 539 | 0.030 |
Why?
|
| Child | 4 | 2022 | 25889 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 78 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 183 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 146 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 48 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 110 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 93 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2014 | 182 | 0.030 |
Why?
|
| Calcineurin | 1 | 2014 | 100 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 167 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 173 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 201 | 0.020 |
Why?
|
| Retreatment | 1 | 2012 | 92 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 504 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 707 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6586 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1381 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 5453 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 109 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2009 | 30 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 1321 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 378 | 0.020 |
Why?
|
| Software | 1 | 2014 | 732 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2009 | 46 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 122 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 258 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1037 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 134 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 226 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 232 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 250 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 236 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 524 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2956 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1136 | 0.020 |
Why?
|
| Palliative Care | 1 | 2010 | 462 | 0.020 |
Why?
|
| Registries | 1 | 2013 | 1591 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 1463 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3978 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2649 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 126 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 280 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 328 | 0.010 |
Why?
|
| Caveolin 2 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 1983 | 38 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2003 | 50 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 725 | 0.010 |
Why?
|
| CD36 Antigens | 1 | 2003 | 42 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 236 | 0.010 |
Why?
|
| Receptor, ErbB-4 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 318 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 437 | 0.010 |
Why?
|
| Calcinosis | 1 | 1983 | 190 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 533 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4918 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2153 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1749 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 911 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1983 | 356 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10970 | 0.010 |
Why?
|
| Critical Care | 1 | 2005 | 699 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2880 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 1759 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 18910 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3725 | 0.010 |
Why?
|